Furthermore, ANP/NPRA signaling seems to regulate obesity, type 2 diabetes, and resistance to insulin (Moro, 2013; Coue et al., 2015). The gene discussed is NPPA; the disease is obesity due to melanocortin 4 receptor deficiency.